|
|
|
|
||
Re: Competitor (DRNA) comments on their HBV program-an analyst even quotes ARWR research!Aspect, thank you for the dicerna dialogue. Can you please clearly identify the significance of the response by Douglas? TIA Jtrader |
return to message board, top of board |